Find out the prime time to gulp down those protein shakes and supercharge your muscle growth. Learn how to optimize protein ...

TORL-1-23 Demonstrates Clinically ... in normal tissues, thus an ideal target for antibody-drug conjugate development. CLDN6 ...

--(BUSINESS WIRE)--Septerna, a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced the dosing of the first participants in its Phase 1 ...

Discover innovative solutions in advancing protein quality control, optimizing efficiency in high-throughput screening ...

In May 2024, Kura Oncology announced completion of enrollment in the Phase 2 portion of KOMET-001, a registration-directed trial of ziftomenib in patients with R/R NPM1-mutant AML. Enrollment of ...

Does creatine cause hair loss? If you’re worried that creatine supplements might cause baldness, check out the scientific ...

(RTTNews) - Lexeo Therapeutics, Inc. (LXEO) Wednesday reported positive interim results from the Phase 1/2 study of its gene therapy candidate LX1001 for the treatment of APOE4-associated Alzheimer's ...

Mace, the company behind London's famous Shard building and Battersea Power Station, have been assigned the task of building phase 1 of the extension by Dubai World Trade Centre (DWTC).

Good day and welcome to the AGCO third-quarter 2024 earnings call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Greg Peterson, ...

Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity data from a clinical phase 1 study of ...

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is ...